Quadria Capital, a healthcare-focussed private equity (PE) fund, is set to invest Rs.500 crore for a 20% stake in drug maker Concord Biotech Ltd, after valuing the company at nearly Rs.2,500 crore, said three people familiar with the development.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
